FDA approves study of ATS Medical's heart valve

08/27/2009 | Forbes

The FDA has allowed ATS Medical to conduct a clinical trial to test its ATS 3f Aortic Bioprosthesis heart valve in patients younger than 60 who need to an aortic valve replacement. The device, which functions like a natural cardiac valve, was cleared by the FDA in October.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA